Cargando…

Breast Cancer in Chinese Females Aged 25 Years and Younger

BACKGROUND: Breast cancer has both aggressive clinicopathological characteristics and a poor prognosis in young females. However, limited information is available for breast cancer in Chinese females aged ≤25 years. Therefore, we aimed to explore prognostic factors for invasive disease-free (iDFS) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lixi, Lv, Dan, Zhai, Jingtong, Zhang, Di, Guan, Xiuwen, Ma, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651374/ https://www.ncbi.nlm.nih.gov/pubmed/34887923 http://dx.doi.org/10.1155/2021/4891936

Ejemplares similares

Antibody-drug conjugates in HER2-positive breast cancer
por: Li, Lixi, et al.
Publicado: (2022)

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022)

Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study
por: Zhang, Di, et al.
Publicado: (2022)

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers
por: Yi, Zongbi, et al.
Publicado: (2020)

Cervical cancer in women aged 25 years or younger: a retrospective study
por: Kong, Yujia, et al.
Publicado: (2019)

Tumor senescence leads to poor survival and therapeutic resistance in human breast cancer
por: Zhai, Jingtong, et al.
Publicado: (2023)

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
por: Yi, Zongbi, et al.
Publicado: (2020)

Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
por: Yi, Zongbi, et al.
Publicado: (2019)

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer
por: Mo, Hongnan, et al.
Publicado: (2020)

Arthroscopic and imaging findings after traumatic hip dislocation in patients younger than 25 years of age
por: Wylie, James D., et al.
Publicado: (2015)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
por: Yi, Zongbi, et al.
Publicado: (2017)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
por: Guan, Xiuwen, et al.
Publicado: (2020)

Impact of the two-dose rubella vaccination regimen on incidence of rubella seronegativity in gravidae aged 25 years and younger
por: Hui, Shuk Yi Annie, et al.
Publicado: (2017)

Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
por: Zhai, Jingtong, et al.
Publicado: (2022)

Worldwide Age at Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study
por: Bidoli, Ettore, et al.
Publicado: (2019)

Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy
por: Li, Lixi, et al.
Publicado: (2022)

Female sex and younger age are associated with hidradenitis suppurativa diagnostic delay
por: Rinderknecht, Fatuma-Ayaan B., et al.
Publicado: (2023)

Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast
por: Zhang, Di, et al.
Publicado: (2022)

High SURF4 expression is associated with poor prognosis of breast cancer
por: Zhai, Jingtong, et al.
Publicado: (2022)

Fracture in Asian Women with Breast Cancer Occurs at Younger Age
por: Tsa, Chun-Hao, et al.
Publicado: (2013)

Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer
por: Guan, Xiuwen, et al.
Publicado: (2019)

Evolution of Female Preference for Younger Males
por: Beck, Christopher W., et al.
Publicado: (2007)

Microvascular Decompression in Patients Aged 30 Years or Younger
por: Karki, Prasanna, et al.
Publicado: (2019)

Breast Cancer Metastasis Associations with Clinicopathological Characteristics in Mexican Women Younger than 40 Years of Age
por: Rosales, Azucena Moreno, et al.
Publicado: (2016)

1841. Younger age and female gender are associated with delayed antibiotics in pediatric sepsis
por: Kandil, Sarah B, et al.
Publicado: (2023)

Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis
por: Wu, Yun, et al.
Publicado: (2022)

Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger
por: Sekine, Ikuo, et al.
Publicado: (1997)

Causes of death in hospitalized children younger than 12 years of age in a Chinese hospital: a 10 year study
por: Zhu, Yueniu, et al.
Publicado: (2018)

Correction: Fracture in Asian Women with Breast Cancer Occurs at Younger Age
por: Tsai, Chun-Hao, et al.
Publicado: (2013)

Analyses of body composition charts among younger and older Chinese children and adolescents aged 5 to 18 years
por: Xiong, Kai-Yu, et al.
Publicado: (2012)

The Association Between Breast Cancer and Blood-Based Methylation of S100P and HYAL2 in the Chinese Population
por: Yin, Qiming, et al.
Publicado: (2020)

Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years
por: Ehret, Anne, et al.
Publicado: (2022)

Lung cancer in young adults aged 35 years or younger: A full-scale analysis and review
por: Liu, Bailong, et al.
Publicado: (2019)

Rhegmatogenous retinal detachment in children 16 years of age or younger
por: AL-Zaaidi, Sultan, et al.
Publicado: (2013)

Total hip arthroplasty in patients 16 years of age or younger
por: Van de Velde, S. K., et al.
Publicado: (2017)

Osteoid Osteoma in Children Younger than 3 Years of Age
por: Laliotis, Nikolaos, et al.
Publicado: (2019)

The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study
por: Liu, Binliang, et al.
Publicado: (2018)

Breast cancer in 30-year-old or younger patients: clinicopathologic characteristics and prognosis
por: Yao, Yongqiang, et al.
Publicado: (2015)

Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis
por: El Saghir, Nagi S., et al.
Publicado: (2023)

Younger age as a prognostic indicator in breast cancer: A cohort study
por: H Kheirelseid, Elrasheid A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_20mtpmkmogl8871uqbv9m8qdlr